Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Slavik

Showing results (91-100 of 134) with videos related to

Pageof 14
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|March 4, 2000
High sensitivity ELISA determination of taxol in various human biological fluidsS R Svojanovsky, K L Egodage, J Wu, et al.
Cancer Treatment Reports|December 1, 1987
Phase II study of spirogermanium in advanced adenocarcinoma of the prostate: a Southwest Oncology Group StudyJ H Saiers, B Blumenstein, M Slavik, et al.
Pharmacology and Therapeutics in Dentistry|January 1, 1975
Changes in preference for NaCl following administration of 6-azauridine and 6-azauridine triacetateF A Catalanotto, M Slavik, D Danilson, et al.
American Journal of Clinical Oncology|June 1, 1984
A phase II study of PALA (NSC 224131) in patients with advanced ovarian carcinoma. A Gynecologic Oncology Group studyH B Muss, M Slavik, B Bundy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 1998
Uncoupling activation-dependent HS1 phosphorylation from nuclear factor of activated T cells transcriptional activation in Jurkat T cells: differential signaling through CD3 and the costimulatory receptors CD2 and CD28J E Hutchcroft, J M Slavik, H Lin, et al.
Investigational New Drugs|February 1, 1990
Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusionC J Fabian, R Molina, M Slavik, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|March 22, 2019
Stereotactic Body Radiotherapy - Current IndicationsP Burkoň, M Slavik, T Kazda, et al.
The Journal of Experimental Medicine|July 9, 2003
Allelic variation of MHC structure alters peptide ligands to induce atypical partial agonistic CD8+ T cell functionDong-Gyun Lim, Jacqueline M Slavik, Katarzyna Bourcier, et al.
Cancer Treatment Reports|May 1, 1984
Phase II clinical study of tamoxifen in advanced endometrial adenocarcinoma: a Gynecologic Oncology Group studyM Slavik, W M Petty, J A Blessing, et al.
Biochemical Pharmacology|April 15, 1990
Stereoselective pharmacokinetics and metabolism of the enantiomers of cyclophosphamide. Preliminary results in humans and rabbitsK A Holm, C G Kindberg, J F Stobaugh, et al.
Pageof 14

Showing results (91-100 of 134) with videos related to

Sort By:
Pageof 14
Journal of Pharmaceutical and Biomedical Analysis|March 4, 2000
High sensitivity ELISA determination of taxol in various human biological fluidsS R Svojanovsky, K L Egodage, J Wu, et al.
Cancer Treatment Reports|December 1, 1987
Phase II study of spirogermanium in advanced adenocarcinoma of the prostate: a Southwest Oncology Group StudyJ H Saiers, B Blumenstein, M Slavik, et al.
Pharmacology and Therapeutics in Dentistry|January 1, 1975
Changes in preference for NaCl following administration of 6-azauridine and 6-azauridine triacetateF A Catalanotto, M Slavik, D Danilson, et al.
American Journal of Clinical Oncology|June 1, 1984
A phase II study of PALA (NSC 224131) in patients with advanced ovarian carcinoma. A Gynecologic Oncology Group studyH B Muss, M Slavik, B Bundy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 1998
Uncoupling activation-dependent HS1 phosphorylation from nuclear factor of activated T cells transcriptional activation in Jurkat T cells: differential signaling through CD3 and the costimulatory receptors CD2 and CD28J E Hutchcroft, J M Slavik, H Lin, et al.
Investigational New Drugs|February 1, 1990
Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusionC J Fabian, R Molina, M Slavik, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|March 22, 2019
Stereotactic Body Radiotherapy - Current IndicationsP Burkoň, M Slavik, T Kazda, et al.
The Journal of Experimental Medicine|July 9, 2003
Allelic variation of MHC structure alters peptide ligands to induce atypical partial agonistic CD8+ T cell functionDong-Gyun Lim, Jacqueline M Slavik, Katarzyna Bourcier, et al.
Cancer Treatment Reports|May 1, 1984
Phase II clinical study of tamoxifen in advanced endometrial adenocarcinoma: a Gynecologic Oncology Group studyM Slavik, W M Petty, J A Blessing, et al.
Biochemical Pharmacology|April 15, 1990
Stereoselective pharmacokinetics and metabolism of the enantiomers of cyclophosphamide. Preliminary results in humans and rabbitsK A Holm, C G Kindberg, J F Stobaugh, et al.
Pageof 14